Pyrrolobenzodiazepine antibody drug conjugates and methods of use
US10639373B2 · kind B2 · utility
1Cited by
26References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 2018 |
| Grant date | May 5, 2020 |
| Priority date | — |
| Expiry date | Oct 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/567
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides antibody-drug conjugates comprising an antibody conjugated to a pyrrolobenzodiazepine drug moiety via a disulfide linker, pyrrolobenzodiazepine linker-drug intermediates, and methods of using the antibody-drug conjugates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.